Mice were treated with an initial i.p. dose of PEG-IGF-I (0.3 or 1 mg/kg) or PBS vehicle, either 3 hrs (both), or 1-day and 5-days (PEG-IGF-I only) post-stroke, with dosing continued twice-weekly thereafter. The gene discussed is IGF1; the disease is stroke disorder.